Key result
Bioinformatics analysis identified 201 robust differentially expressed genes and confirmed ASPN, COL1A1, and FMOD as reliable hub genes and potential diagnostic biomarkers for heart failure.
Why the study?
Heart failure is the end stage of cardiovascular diseases with high mortality, and novel diagnostic and therapeutic biomarkers are urgently required.
Bioinformatics analysis and tissue validation identified ASPN, COL1A1, and FMOD as potential diagnostic biomarkers and therapeutic targets for heart failure.
Answers are grounded in this paper and cite their sources.
These HF hub genes are hypothesis-generating; prospective validation needed before biomarker or therapeutic consideration.
Background: Heart failure (HF) is the end stage of various cardiovascular diseases with a high mortality rate. Novel diagnostic and therapeutic biomarkers for HF are urgently required. Our research aims to identify HF-related hub genes and regulatory networks using bioinformatics and validation assays. Methods: Using four RNA-seq datasets in the Gene Expression Omnibus (GEO) database, we screened differentially expressed genes (DEGs) of HF using Removal of Unwanted Variation from RNA-seq data (RUVSeq) and the robust rank aggregation (RRA) method. Then, hub genes were recognized using the STRING database and Cytoscape software with cytoHubba plug-in. Furthermore, reliable hub genes were validated by the GEO microarray datasets and quantitative reverse transcription polymerase chain reaction (qRT-PCR) using heart tissues from patients with HF and non-failing donors (NFDs). In addition, R packages "clusterProfiler" and "GSVA" were utilized for enrichment analysis. Moreover, the transcription factor (TF)-DEG regulatory network was constructed by Cytoscape and verified in a microarray dataset. Results: were confirmed as reliable hub genes through microarray datasets and qRT-PCR validation. Functional analysis showed that the DEGs and hub genes were enriched in T-cell-mediated immune response and myocardial glucose metabolism, which were closely associated with myocardial fibrosis. In addition, the TF-DEG regulatory network was constructed, and 13 significant TF-DEG pairs were finally identified. Conclusion: as potential diagnostic biomarkers for HF. The results provide new insights into the underlying mechanisms and effective treatments of HF.
No takes yet. Share an insight, caveat, or question.
Tu et al. (2022) studied Heart failure (n=138). Heart failure vs. Non-failing donors was evaluated on Identification of robust differentially expressed genes (DEGs) and hub genes. Bioinformatics analysis identified 201 robust differentially expressed genes and confirmed ASPN, COL1A1, and FMOD as reliable hub genes and potential diagnostic biomarkers for heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: